Abstract WMP3: DEFUSE-3 Eligible but DAWN Ineligible Patients Treated Within 16-24 Hours: Results From BEST Prospective Cohort Study
Sign Up to like & getrecommendations! Published in 2019 at "Stroke"
DOI: 10.1161/str.50.suppl_1.wmp3
Abstract: Background: The 2018 ASA guidelines recommend endovascular stroke treatment (EVT) for patients who meet DEFUSE 3 (D3) trial criteria within 6-16 hrs and those who meet DAWN criteria within 6-24 hrs... read more here.
Keywords: wmp3 defuse; abstract wmp3; dawn; eligible dawn ... See more keywords